1
Clinical Trials associated with TRBC1/2-Targeted CAR-T Cell(Second Affiliated Hospital Zhejiang University College)Clinical Study of Umbilical Cord Blood-Derived CAR-NK Cell Therapy Targeting TRBC1/2 for Relapsed/Refractory T-Cell Lymphoma
This study aims to evaluate the safety and efficacy of Umbilical Cord Blood-Derived CAR-NK Cell Therapy Targeting TRBC1/2 (TRBC1/2 CAR-NK cells) in patients with refractory or relapsed peripheral T-cell lymphoma (PTCL).
100 Clinical Results associated with TRBC1/2-Targeted CAR-T Cell(Second Affiliated Hospital Zhejiang University College)
100 Translational Medicine associated with TRBC1/2-Targeted CAR-T Cell(Second Affiliated Hospital Zhejiang University College)
100 Patents (Medical) associated with TRBC1/2-Targeted CAR-T Cell(Second Affiliated Hospital Zhejiang University College)
100 Deals associated with TRBC1/2-Targeted CAR-T Cell(Second Affiliated Hospital Zhejiang University College)